Effector Cell Generation Platform
Our proprietary immune effector cell generation enables the development of scalable, cost-effective, and biologically consistent cell therapies.
We use umbilical cord blood (UCB)-derived CD34+ hematopoietic stem cells that are then differentiated into NK cells as the starting material for our GEAR-NK cells.
What makes UCB-Derived Stem Cells Superior?
UCB Stem Cells are YOUNG!
UCB-derived stem cells are very young (they have short telomeres) and, so allow for the subsequent immune cell therapy to proliferate at very high levels for a prolonged period of time.
UCB Stem Cells are HEALTHY!
These cells have been being nurtured in a very protected environment before we gain access to them. So, they are relatively clean of cellular damage and viral infection that would otherwise compromise cell therapy efficacy.
UCB Stem Cells are ABUNDANT!
Umbilical cord blood is often considered medical waste due to its limited applications in traditional medicine. However, this abundance makes it an easily accessible resource for stem cell therapy and research, as it is typically discarded after birth unless specifically collected.
